These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19827)
1. Influence of catecholamine-derived alkaloids and beta-adrenergic blocking agents on stereospecific binding of 3H-naloxone. Tampier L; Alpers HS; Davis VE Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):731-4. PubMed ID: 19827 [TBL] [Abstract][Full Text] [Related]
2. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954 [TBL] [Abstract][Full Text] [Related]
8. [Opiate receptor binding of naloxone in the rat brain: effect of sodium ions]. Balashov AM; Petrichenko OB; Aliab'eva TN; Panchenko LF Biokhimiia; 1988 Sep; 53(9):1527-31. PubMed ID: 2849481 [TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors. Oktem HA; Apaydin S Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651 [TBL] [Abstract][Full Text] [Related]
10. Effect of non-opiate antagonists on stereospecific opiate receptor binding of tritiated naloxone. Charalampous KD; Askew WE Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):615-22. PubMed ID: 4153655 [No Abstract] [Full Text] [Related]
11. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain. Buller KM; Hamlin AS; Osborne PB Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445 [TBL] [Abstract][Full Text] [Related]
12. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex. Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797 [TBL] [Abstract][Full Text] [Related]
13. [Interaction of various tetrahydroisoquinoline alkaloids with opiate receptors in the rat hypothalamus and midbrain]. Panchenko LF; Brusov OS; Balashov AM; Grinevich VP; Ostrovskiĭ IuM Vopr Med Khim; 1982; 28(5):88-92. PubMed ID: 6294993 [TBL] [Abstract][Full Text] [Related]
14. Influence of catecholaminergic agents on narcotic binding in brain. Cicero TJ; Wilcox CE; Meyer ER; Michael H Arch Int Pharmacodyn Ther; 1975 Dec; 218(2):221-30. PubMed ID: 1212020 [TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
16. The interaction of phenoxybenzamine with the mouse brain opiate receptor. Spiehler V; Fairhurst AS; Randall LO Mol Pharmacol; 1978 Jul; 14(4):587-95. PubMed ID: 28470 [No Abstract] [Full Text] [Related]
17. [Effect of some isoquinoline alkaloids on monoamines in the rat brain]. Liu GQ; Jiang Y; Peng G; Ibrahim ; Zhou LQ Yao Xue Xue Bao; 1985 Aug; 20(8):566-70. PubMed ID: 2870602 [No Abstract] [Full Text] [Related]
18. Effects of catecholamine-related mammalian alkaloids on spontaneous and vasopressin-induced behavior in mice. Meisenberg G; Simmons WH; Collins MA Pharmacol Biochem Behav; 1984 Mar; 20(3):355-60. PubMed ID: 6324242 [TBL] [Abstract][Full Text] [Related]
19. Effects of beta-adrenergic blocking agents on specific binding of [3H]D-Ala2-Met5-enkephalinamide and [3H]naloxone. Takayama H; Ogawa N; Asanuma M; Hirata H; Ogura T; Ota Z Acta Med Okayama; 1991 Oct; 45(5):295-9. PubMed ID: 1684486 [TBL] [Abstract][Full Text] [Related]
20. [Alpha interferon interaction with opiate receptors in the rat brain]. Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]